These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 31993501)

  • 1. Molecular switches in signaling networks as a mechanism of action for oncogenic mutations in proximity of tyrosine residues.
    Emdal KB; Lundby A
    Mol Cell Oncol; 2020; 7(1):1692643. PubMed ID: 31993501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic Mutations Rewire Signaling Pathways by Switching Protein Recruitment to Phosphotyrosine Sites.
    Lundby A; Franciosa G; Emdal KB; Refsgaard JC; Gnosa SP; Bekker-Jensen DB; Secher A; Maurya SR; Paul I; Mendez BL; Kelstrup CD; Francavilla C; Kveiborg M; Montoya G; Jensen LJ; Olsen JV
    Cell; 2019 Oct; 179(2):543-560.e26. PubMed ID: 31585087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.
    Rush J; Moritz A; Lee KA; Guo A; Goss VL; Spek EJ; Zhang H; Zha XM; Polakiewicz RD; Comb MJ
    Nat Biotechnol; 2005 Jan; 23(1):94-101. PubMed ID: 15592455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters.
    Abe Y; Nagano M; Tada A; Adachi J; Tomonaga T
    J Proteome Res; 2017 Feb; 16(2):1077-1086. PubMed ID: 28152594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine Proteomics.
    Haake SM; Li J; Bai Y; Kinose F; Fang B; Welsh EA; Zent R; Dhillon J; Pow-Sang JM; Chen YA; Koomen JM; Rathmell WK; Fishman M; Haura EB
    Clin Cancer Res; 2016 Nov; 22(22):5605-5616. PubMed ID: 27220961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma.
    Emdal KB; Pedersen AK; Bekker-Jensen DB; Lundby A; Claeys S; De Preter K; Speleman F; Francavilla C; Olsen JV
    Sci Signal; 2018 Nov; 11(557):. PubMed ID: 30459283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Analysis of Tyrosine Kinase Signaling Across Differentially Embedded Human Glioblastoma Tumors.
    Johnson H; White FM
    Methods Mol Biol; 2018; 1711():149-164. PubMed ID: 29344889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: identification of new signaling elements.
    Gorla L; Mondellini P; Cuccuru G; Miccichè F; Cassinelli G; Cremona M; Pierotti MA; Lanzi C; Bongarzone I
    Mol Carcinog; 2009 Mar; 48(3):220-231. PubMed ID: 18756447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiproteomic and Transcriptomic Analysis of Oncogenic β-Catenin Molecular Networks.
    Ewing RM; Song J; Gokulrangan G; Bai S; Bowler EH; Bolton R; Skipp P; Wang Y; Wang Z
    J Proteome Res; 2018 Jun; 17(6):2216-2225. PubMed ID: 29747501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative proteomic analysis of phosphotyrosine-mediated cellular signaling networks.
    Zhang Y; Wolf-Yadlin A; White FM
    Methods Mol Biol; 2007; 359():203-12. PubMed ID: 17484120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-Scale Phosphoproteomics Reveals Shp-2 Phosphatase-Dependent Regulators of Pdgf Receptor Signaling.
    Batth TS; Papetti M; Pfeiffer A; Tollenaere MAX; Francavilla C; Olsen JV
    Cell Rep; 2018 Mar; 22(10):2784-2796. PubMed ID: 29514104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder.
    Bian Y; Li L; Dong M; Liu X; Kaneko T; Cheng K; Liu H; Voss C; Cao X; Wang Y; Litchfield D; Ye M; Li SS; Zou H
    Nat Chem Biol; 2016 Nov; 12(11):959-966. PubMed ID: 27642862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes.
    Choudhary C; Olsen JV; Brandts C; Cox J; Reddy PN; Böhmer FD; Gerke V; Schmidt-Arras DE; Berdel WE; Müller-Tidow C; Mann M; Serve H
    Mol Cell; 2009 Oct; 36(2):326-39. PubMed ID: 19854140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the promiscuous nature of tyrosine kinase inhibitors assessed in A431 epidermoid carcinoma cells by both chemical- and phosphoproteomics.
    Giansanti P; Preisinger C; Huber KV; Gridling M; Superti-Furga G; Bennett KL; Heck AJ
    ACS Chem Biol; 2014 Jul; 9(7):1490-8. PubMed ID: 24804581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor.
    Tong J; Taylor P; Jovceva E; St-Germain JR; Jin LL; Nikolic A; Gu X; Li ZH; Trudel S; Moran MF
    J Proteome Res; 2008 Mar; 7(3):1067-77. PubMed ID: 18271526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphotyrosine interactome of the ErbB-receptor kinase family.
    Schulze WX; Deng L; Mann M
    Mol Syst Biol; 2005; 1():2005.0008. PubMed ID: 16729043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways.
    Yan GR; Xiao CL; He GW; Yin XF; Chen NP; Cao Y; He QY
    Proteomics; 2010 Mar; 10(5):976-86. PubMed ID: 20049867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics.
    Zhang X; Belkina N; Jacob HK; Maity T; Biswas R; Venugopalan A; Shaw PG; Kim MS; Chaerkady R; Pandey A; Guha U
    Proteomics; 2015 Jan; 15(2-3):340-55. PubMed ID: 25404012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep Phospho- and Phosphotyrosine Proteomics Identified Active Kinases and Phosphorylation Networks in Colorectal Cancer Cell Lines Resistant to Cetuximab.
    Abe Y; Nagano M; Kuga T; Tada A; Isoyama J; Adachi J; Tomonaga T
    Sci Rep; 2017 Sep; 7(1):10463. PubMed ID: 28874695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.